Pharmacy and regulatory commentators have raised the same concern about transdermal "natural GLP-1" supplements: the marketing implies drug-like efficacy while the fine print disclaims drug status, a combination that sits uneasily with federal advertising rules
Tendon and Ligament Support : Preclinical studies investigate mechanisms that may influence structural repair in connective tissues under stress or injury
Better known to the public by brand names such as Ozempic, Wegovy, Trulicity, Rybelsus, Victoza, Saxenda, and Mounjaro, these glucose-lowering medications, which were initially approved for the treatment of patients with type 2 diabetes, have made headlines recently thanks to their demonstrated effectiveness at treating obesity and helping people with or without diabetes lose weight
Data availability The source data supporting the findings of this article are included in this article and its supplementary information files
Experts said the study was promising but that more research is needed before doctors prescribe the drugs to people who are not overweight
